AROUSAL;
ARTICLE;
CLIMACTERIUM;
CLINICAL TRIAL;
COMORBIDITY;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG APPROVAL;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MARKETING;
DRUG MECHANISM;
DRUG STRUCTURE;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HAMILTON SCALE;
HEADACHE;
HUMAN;
INFORMATION PROCESSING;
INSOMNIA;
MAJOR DEPRESSION;
META ANALYSIS;
PATENT;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
SLEEP;
STEREOISOMERISM;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
UNITED STATES;
Sepracor Inc. Sepracor Announces Conditional Expansion of Eszopiclone Agreement Media Release: 13 Jul Available from URL:
Sepracor Inc. Sepracor Announces Conditional Expansion of Eszopiclone Agreement. Media Release: 13 Jul 2004. Available from URL: http://www.sepracor.com
(2004)
2
16844373512
Paul Royalty Fund II LP. Paul Royalty Acquires Estorra U.S. Royalty Rights From Aventis For Up to $115 Million Media Release: 9 Aug Available from URL
Paul Royalty Fund II LP. Paul Royalty Acquires Estorra U.S. Royalty Rights From Aventis For Up to $115 Million. Media Release: 9 Aug 2004. Available from URL http://www.paul-capital.com
(2004)
3
16844372856
Sepracor Inc. LUNESTA(TM) Brand Eszopiclone, Formerly ESTORRA, Approved by FDA for Treatment of Insomnia Media Release: 16 Dec Available from URL:
Sepracor Inc. LUNESTA(TM) Brand Eszopiclone, Formerly ESTORRA, Approved by FDA for Treatment of Insomnia. Media Release: 16 Dec 2004. Available from URL: http://www.sepracor.com
(2004)
4
16844380153
Sepracor Inc. Sepracor Revises Timing of Commercial Availability for LUNESTA(TM) Brand Eszopiclone Media Release: 11 Jan Available from URL:
Sepracor Inc. Sepracor Revises Timing of Commercial Availability for LUNESTA(TM) Brand Eszopiclone. Media Release: 11 Jan 2005. Available from URL: http://www.sepracor.com
(2005)
5
16844375318
Sepracor Inc. Sepracor Submits U.S. New Drug Application for ESTORRA(TM) Brand Eszopiclone for Treatment of Insomnia Media Release: 3 Feb Available from URL:
Sepracor Inc. Sepracor Submits U.S. New Drug Application for ESTORRA(TM) Brand Eszopiclone for Treatment of Insomnia. Media Release: 3 Feb 2003. Available from URL: http://www.sepracor.com
(2003)
6
16844383105
Sepracor Inc. Sepracor Announces FDA Acceptance of ESTORRA(TM) NDA Resubmission and Issuance of Class 2 Review Designation Media Release: 15 Jul Available from URL:
Sepracor Inc. Sepracor Announces FDA Acceptance of ESTORRA(TM) NDA Resubmission and Issuance of Class 2 Review Designation. Media Release: 15 Jul 2004. Available from URL: http://www.sepracor.com
(2004)
7
16844377632
Sepracor Inc. Sepracor Announces Second Quarter 2004 Operating Results Media Release: 27 Jul Available from URL:
Sepracor Inc. Sepracor Announces Second Quarter 2004 Operating Results. Media Release: 27 Jul 2004. Available from URL: http://www.sepracor.com
(2004)
8
16844373263
Sepracor Inc. Preliminary Results Show Improvement for Insomnia Patients with Co-Existing Depression Who Were Treated with Sepracor's Lunesta(TM) Media Release: 12 Jan Available from URL:
Sepracor Inc. Preliminary Results Show Improvement for Insomnia Patients with Co-Existing Depression Who Were Treated with Sepracor's Lunesta(TM). Media Release: 12 Jan 2005. Available from URL: http://www.sepracor.com
(2005)
9
16844382974
Sepracor Inc. ESTORRA(TM) Phase IIIB Insomnia Studies Underway in Subjects With Depression, Rheumatoid Arthritis And Perimenopause Media Release: 18 Dec Available from:URL: Summary in 4 parts (Part A)
Sepracor Inc. ESTORRA(TM) Phase IIIB Insomnia Studies Underway in Subjects With Depression, Rheumatoid Arthritis And Perimenopause. Media Release: 18 Dec 2003. Available from:URL: http://www.sepracor.com. Summary in 4 parts (Part A)
(2003)
10
16844362566
Sepracor Inc. Sepracor Announces Fourth Quarter and Full Year 2003 Operating Results Media Release: 22 Jan Available from URL:
Sepracor Inc. Sepracor Announces Fourth Quarter and Full Year 2003 Operating Results. Media Release: 22 Jan 2004. Available from URL: http://www.sepracor.com
(2004)
11
16844378159
Sepracor Inc. ESTORRA(TM) Data Presented at Associated Professional Sleep Societies Meeting Poster Session Media Release: 8 Jun Available from URL:
Sepracor Inc. ESTORRA(TM) Data Presented at Associated Professional Sleep Societies Meeting Poster Session. Media Release: 8 Jun 2004. Available from URL: http://www.sepracor.com
(2004)
12
16844375857
Sepracor Inc. ESTORRA(TM) Phase III Elderly Data Presented at Eleventh International Congress of International Psychogeriatric Association Media Release: 22 Aug Available from URL:
Sepracor Inc. ESTORRA(TM) Phase III Elderly Data Presented at Eleventh International Congress of International Psychogeriatric Association. Media Release: 22 Aug 2003. Available from URL: http://www.sepracor.com
(2003)
13
16844370979
Sepracor Inc. ESTORRA(TM) Six-Week Phase III Study Presented At Associated Professional Sleep Societies Meeting Media Release: 9 Jun Available from URL:
Sepracor Inc. ESTORRA(TM) Six-Week Phase III Study Presented At Associated Professional Sleep Societies Meeting. Media Release: 9 Jun 2003. Available from URL: http://www.sepracor.com
(2003)
14
16844366965
Sepracor Inc. ESTORRA(TM) Data Presented at American Psychiatric Association Meeting Media Release: 6 May Available from URL:
Sepracor Inc. ESTORRA(TM) Data Presented at American Psychiatric Association Meeting. Media Release: 6 May 2004. Available from URL: http://www.sepracor.com
(2004)
15
16844387356
Sepracor Inc. ESTORRA(TM) Phase III Data Presented at American Psychiatric Association Meeting Media Release: 21 May Available from:URL:
Sepracor Inc. ESTORRA(TM) Phase III Data Presented at American Psychiatric Association Meeting. Media Release: 21 May 2003. Available from:URL: http://www.sepracor.com
(2003)
16
16844383239
Sepracor Inc. ESTORRA(TM) One-Year Data Presented At Associated Professional Sleep Societies Meeting Media Release: 9 Jun Available from URL:
Sepracor Inc. ESTORRA(TM) One-Year Data Presented At Associated Professional Sleep Societies Meeting. Media Release: 9 Jun 2003. Available from URL: http://www.sepracor.com
(2003)
17
16844381865
An assessment of the longterm efficacy and safety of eszopiclone over 12 months of nightly treatments in patients with chronic insomnia
157th Annual Meeting of the American Psychiatric Association: New Research Abstracts: 315 (plus notes) abstr NR838, 6 May
Roth T, Krystal AD, Wessel T, et al. An assessment of the longterm efficacy and safety of eszopiclone over 12 months of nightly treatments in patients with chronic insomnia. 157th Annual Meeting of the American Psychiatric Association: New Research Abstracts: 315 (plus notes) abstr. NR838, 6 May 2004
Sepracor Inc. Sepracor Completes Large-scale Efficacy Study for (S)-Zopiclone Media Release: [2 pages], 28 Aug Available from URL:
Sepracor Inc. Sepracor completes large-scale efficacy study for (S)-Zopiclone. Media Release: [2 pages], 28 Aug 2000. Available from URL: http://www.sepracor.com
(2000)
19
16844365349
Sepracor Inc. ESTORRA(TM) Data Presented at American College of Obstetricians and Gynecologists Meeting Media Release: 5 May Available from URL:
Sepracor Inc. ESTORRA(TM) Data Presented at American College of Obstetricians and Gynecologists Meeting. Media Release: 5 May 2004. Available from URL: http://www.sepracor.com
(2004)
* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.